Business Description
TAO Synergies Inc
NAICS : 541511
SIC : 7371
ISIN : US87167T3005
Share Class Description:
TAOX: Ordinary SharesTotal Employee Number:
4Description
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.84 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 63.8 | |||||
3-Year EPS without NRI Growth Rate | 62.7 | |||||
3-Year FCF Growth Rate | 63.6 | |||||
3-Year Book Growth Rate | -70.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.61 | |||||
9-Day RSI | 33.77 | |||||
14-Day RSI | 37.46 | |||||
3-1 Month Momentum % | -34.68 | |||||
6-1 Month Momentum % | -25.98 | |||||
12-1 Month Momentum % | -61.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 27.39 | |||||
Quick Ratio | 27.39 | |||||
Cash Ratio | 3.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -194.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1351.31 | |||||
Net Margin % | -3614.54 | |||||
EBITDA Margin % | -1350.73 | |||||
FCF Margin % | -883.43 | |||||
OCF Margin % | -883.43 | |||||
ROE % | -139.48 | |||||
ROA % | -112.67 | |||||
ROIC % | -71.04 | |||||
3-Year ROIIC % | 38.31 | |||||
ROC (Joel Greenblatt) % | -72.42 | |||||
ROCE % | -44.18 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 22.74 | |||||
PB Ratio | 1.07 | |||||
Price-to-Tangible-Book | 1.07 | |||||
EV-to-EBIT | -2.59 | |||||
EV-to-Forward-EBIT | -1.55 | |||||
EV-to-EBITDA | -2.59 | |||||
EV-to-Revenue | 34.98 | |||||
EV-to-FCF | -3.96 | |||||
| Price-to-Net-Current-Asset-Value | 1.11 | |||||
Earnings Yield (Greenblatt) % | -38.61 | |||||
FCF Yield % | -24.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TAOX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TAO Synergies Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.688 | ||
| EPS (TTM) ($) | -13.433 | ||
| Beta | 1.6046 | ||
| 3-Year Sharpe Ratio | -0.04 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 90.06 | ||
| 14-Day RSI | 37.46 | ||
| 14-Day ATR ($) | 0.349765 | ||
| 20-Day SMA ($) | 3.6565 | ||
| 12-1 Month Momentum % | -61.91 | ||
| 52-Week Range ($) | 3.22 - 10 | ||
| Shares Outstanding (Mil) | 7.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TAO Synergies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TAO Synergies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-18 11:00 | In 146 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 110 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 19 days | ||
| First quarter earnings results for 2026 | 2026-05-13 | 6.03 (-5.04%) | ||
| Annual report for 2025 | 2026-03-31 | 5.37 (+2.48%) | ||
| General meeting for 2025 | 2025-12-18 11:00 | 5.02 (-5.10%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 6.56 (-9.64%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 9.56 (+13.27%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 2.40 (-3.45%) | ||
| Annual report for 2024 | 2025-03-27 | 2.64 (+0.00%) |
Show
Entries
TAO Synergies Inc Frequently Asked Questions
What is TAO Synergies Inc(TAOX)'s stock price today?
The current price of TAOX is $3.32. The 52 week high of TAOX is $10.00 and 52 week low is $3.22.
When is next earnings date of TAO Synergies Inc(TAOX)?
The next earnings date of TAO Synergies Inc(TAOX) is 2026-08-14 Est..
Does TAO Synergies Inc(TAOX) pay dividends? If so, how much?
TAO Synergies Inc(TAOX) does not pay dividend.
Guru Commentaries on NAS:TAOX
No articles.
Press Release
Articles on TAO Synergies Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers